Alicia Garrido is Neurologist and research fellow at Parkinson's disease and movement disorders unit of Hospital Clínic de Barcelona. Her research has focused on the genetic forms of the  Parkinson's disease (PD)  particularly PD caused by mutations on the Leucine Rich Repeat Kinase 2 (LRRK2) gene, and also on the study prodromal phase of the disease. She is currently sub-investigator and coordinator of  the Parkinson's Progression Markers Initiative, funded by the Michael J Fox Foundation, in Hospital Clínic Barcelona, since 2015. She also collaborates on the recruitment of patients, and obtention of  clinical data for other projects of the Parkinson's disease and movement disorders Unit.